| Trial ID: | L2679 |
| Source ID: | NCT02500329
|
| Associated Drug: |
Gemigliptin
|
| Title: |
Effect of Gemigliptin or Acarbose on Endothelial Function in Type 2 DM Patients
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Endothelial Function|Type 2 Diabetes|Gemigliptin|Acarbose
|
| Interventions: |
DRUG: Gemigliptin|DRUG: Acarbose
|
| Outcome Measures: |
Primary: endothelial function (reactive hyperemic index), 4 weeks | Secondary: Fasting plasma glucose, 4 weeks|Postprandial 2hour glucose, 4 weeks|Glycated albumin, 4 weeks
|
| Sponsor/Collaborators: |
Sponsor: Seoul National University Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
54
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2014-09
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2015-07-16
|
| Locations: |
Boramae medical center, Seoul, 156-707, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT02500329
|
